Switzerland· 67393002
Cellcept 250 mg, Kapseln
A mycophenolic acid product containing mofetili mycophenolas, registered in Switzerland by APS-Arzneimittel-Parallelimport- Service AG and dispensed under Swissmedic category B. The same ATC class is registered in 15 of our 19 countries.
Checked against Swissmedic (Switzerland) on
Informational only — not a medical device.
Where it is registered
Mycophenolic acid is registered in 15 of 19 countries.
Countries holding a registration under ATC L04AA06 (mycophenolic acid), each read from that country’s own register.
- This record: Switzerland, from Swissmedic (Switzerland)
- 9 of them publish a price we can compare per daily dose
Mycophenolic acid · ATC L04AA06
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of mycophenolic acid costs, country by country.
Normalised to the WHO defined daily dose (2 g), so markets compare like for like.
- Switzerland: $9.57 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Mycophenolic acid · price per daily dose (2 g)
USD · FX 28 Sept 2026
- CH Switzerland$9.57
- IT Italy$8.14
The record
At a glance
Swissmedic (Switzerland)- Active substance
- mofetili mycophenolas
- Manufacturer
- APS-Arzneimittel-Parallelimport- Service AG
- Country
- Switzerland (CH)
- ATC code
- L04AA06
- ATC class
- Mycophenolic acid
- Defined daily dose
- 2 g, O
- Swissmedic category
- B
- Reimbursed
- No
- Source register
- Swissmedic (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
350 interactions on record for mycophenolic acid.
Graded by severity as the source publishes them — 50 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Mycophenolic acid · interactions on record
350 records
- 50 severe
- 179 moderate
- 20 minor
- 75 info
Most severe, free to view
- Medicinal charcoalA07BA01severe
- ColestyramineC10AC01severe
- ColestipolC10AC02severe
- ColesevelamC10AC04severe
26 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Mycophenolic acid in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsCellCept capsules, capsule 250 mgRoche Registration GmbH
- PolandCellCeptRoche Registration GmbH
- IcelandCellceptRoche Registration GmbH*
- CanadaAPO-MYCOPHENOLIC ACIDAPOTEX INC
- SwedenMyfortic 180 mg EnterotablettEbb Medical AB
- ItalyACIDO MICOFENOLICO ACCORDACCORD HEALTHCARE B.V.
- United KingdomCeptava 180mg gastro-resistant tabletsSandoz Ltd
- GermanyMycophenolat Mofetil AccordAccord Healthcare B.V.
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Mycophenolsäure Accord, Myfortic
- Belgium · Myfortic
- Bulgaria · Mифортик
- Cyprus · Myfortic
- Czechia · Mycophenolic Acid Accord, Myfortic
- Germany · Mycophenolat Mofetil Accord, Mycophenolatmofetil Heumann
- Denmark · Myastad, Mycophenolsyre Accord
- Estonia · Myfortic
- Spain · Ácido Micofenólico Stada, Myfortic
- Finland · Myastad, Myfortic
- France · Acide Mycophenolique Tillomed, Myfortic
- United Kingdom (Northern Ireland) · Mycophenolic Acid Accord Healthcare, Myfortic
- Greece · Myfortic
- Croatia · Mikofenolatna Kiselina Accord, Myfortic
- Hungary · Mikofenolsav Tillomed, Myfortic
- Ireland · Myfortic
- Iceland · Mycofenolsýra Accord, Myfortic
- Italy · Acido Micofenolico Accord, Acido Micofenolico Tillomed
- Lithuania · Myfortic
- Luxembourg · Myfortic
- Latvia · Myfortic
- Malta · Myfortic
- Netherlands · Mycofenolzuur Accord, Myfortic
- Norway · Myfortic, Mykofenolsyre Accord
- Poland · Marelim, Myfortic
- Portugal · Ácido Micofenólico Accord, Ácido Micofenólico Tillomed
- Romania · Myfortic
- Sweden · Myfortic, Mykofenolsyra Accord
- Slovenia · Myfortic
- Slovakia · Myfortic
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cf4c4ac4-7064-441d-b786-05bc3627789f GET /v1/drugs/cf4c4ac4-7064-441d-b786-05bc3627789f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{}See everything about mycophenolic acid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.